N/A
N=112
Predictability of OSA With a Subjective Screening Scale (OSASSS1)
Obstructive Sleep Apnea · OSA
Bottom Line
View on ClinicalTrials.gov: NCT06092710 ↗Enrolled (actual)
112
Serious AEs
0.0%
Results posted
Jun 2025
Primary outcome: Primary: Test of Perception of Variations in the Passage of an Airflow Through the Rhino-oro-pharyngeal Passages According to the Categories of Items Used in the OSASSS Subjective Perception Scale — 5; 4 score on a scale — p=0.05572
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- neuro-sensorial subjective evaluation of the airways collapsibility (Diagnostic_test)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Center for Sleep Medicine - Clinique André Renard
- Primary completion
- Jun 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Test of Perception of Variations in the Passage of an Airflow Through the Rhino-oro-pharyngeal Passages According to the Categories of Items Used in the OSASSS Subjective Perception Scale |
5; 4 | 0.05572 |
| PRIMARY Predictability of OSA Based on a Score Using Subjective Perception of Airway Collapsibility Between OSA and Control Subjects to Validate a Clinical Screening Tool |
8.63; 5.92 | 0.00000106 sig |
| SECONDARY Predictive Value on the Severity of OSA of the Subjective Upper Airway Collapsibility Perception Scale |
5.92; 8.78; 8.47; 8.75; 8.26; 12.89 | 0.0142266 sig |
Summary
the study aims to evaluate the accuracy correlation between subjective perception of the air flow through airways from patients and survey and/or polysomnography they spent, using a brief clinical protocol they answered with a manual therapist
Eligibility Criteria
Inclusion Criteria
- Female or male subjects aged 18 to 77 years old
- subjects who have performed a PSG at the sleep medicine center André Renard for the study group
- subjects with no sleep disorder on sleep survey for the control group
- Subjects who agree to comply with the requirements of the study.
- Subjects who are of age (and know how to read and write) who have given their informed, explicit consent in advance to any procedure related to the trial, the study or the investigation conducted on human beings, with the objective of developing knowledge specific to the exercise of health care professions, as set out in Royal Decree No. 78 of 10 November 1967 on the practice of the health care professions (Act of 27 December 2005)
Exclusion Criteria
- subjects with acute infections
- subjects with trauma within the last 72 hours
- subjects who already benefit from OSA treatment
- subjects with known perceptual disorders, for example post-stroke
- subjects with current or recent chemotherapy and radiotherapy treatment
- Pregnant women
- Criteria related to prior or concurrent treatments:
Treatment with antipsychotics, anxiolytics, soporifics or muscle relaxants started within the two months preceding the study.
Treatment with intraoral implants during the study or in the two months preceding the study
Data sourced from ClinicalTrials.gov (NCT06092710). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.